# Omega Funds: portfolio, investments and team > Omega Funds is a vc firm based in United States. 104 investments on record, 17 in the last 12 months, latest Sept 2026. Source: https://millionrounds.com/fund/omega-funds (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Omega Funds Last cheque observed Sep 2026; 104 cheques on record. Email Deploying now New fund $580M, Apr 2025 VC firm Buyout Growth Pre-seed Oncology Immunology Rare_diseases Follow Omega Funds and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fomega-funds) Deploying now **89%** of best year **17** **cheques in 12 months**, 104 on record Since the last cheque **38** days **00** hrs **00** min **00** sec Median round **$88M** Rounds led **8 of 104** Sole investor **5 rounds** Exits **1 from the portfolio** Mostly in **United States, 83%** Pitch Omega Funds ## Omega Funds highlights - 01 17 cheques in the last 12 months - 02 Mostly Series A and Series B: 63% of its rounds - 03 Sole investor in 5 rounds, median $2.6M - 04 1 exits from the portfolio ## What they do > We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. From their own website - **Type:** VC firm - **Cheque size:** Not stated - **Stages:** Buyout Growth Pre-seed Seed Series A Series B - **Sectors:** Oncology Immunology Rare_diseases - **Based in:** Boston, United States - **Cold pitches:** Not accepted ## The record Every round we can evidence, newest first **104 appearances** - **2026** 14 rounds - **Sept** **[Anaconda Biomed](https://millionrounds.com/company/anaconda-biomed)** Series C · ES · Asabys **$56M** *Led* - **Sept** **[Beta Bionics](https://millionrounds.com/company/beta-bionics)** US **$173M** With 3 others - **Aug** **[Vaderis Therapeutics](https://millionrounds.com/company/vaderis-therapeutics)** Series B · CH · Firms' own news pages **$152M** With 8 others - **May** **[Editas Medicine](https://millionrounds.com/company/editas-medicine)** US **$125M** With 3 others - **May** **[Sana Biotechnology](https://millionrounds.com/company/sana-biotechnology)** US **$69M** With 4 others - **Apr** **[Trevi Therapeutics](https://millionrounds.com/company/trevi-therapeutics)** US **$173M** With 3 others - **Apr** **[Spruce Biosciences](https://millionrounds.com/company/spruce-biosciences)** US **$60M** With 2 others - **Feb** **[Alveus Therapeutics Inc.](https://millionrounds.com/company/alveus-therapeutics-inc)** Series A · US · Seroba Life Sciences **$197M** *Led* - **Feb** **[Beam Therapeutics](https://millionrounds.com/company/beam-therapeutics)** Debt · US **$100M** With 5 others - **Jan** **[Alveus Therapeutics](https://millionrounds.com/company/alveus-therapeutics)** Series A · US · Avego Management **$160M** *Led* - **Jan** **[Spruce Biosciences](https://millionrounds.com/company/spruce-biosciences)** Venture · US **Undisclosed** With 3 others - **Jan** **[Alumis](https://millionrounds.com/company/alumis)** US **$345M** With 6 others - **Jan** **[Caldera Therapeutics](https://millionrounds.com/company/caldera-therapeutics)** Series A · US **$38M** With 4 others - **Jan** **[Spiro Medical](https://millionrounds.com/company/spiro-medical)** Series A · US **$67M** With 4 others - **2025** 14 rounds - **Dec** **[Kestra Medical Technologies, Inc.](https://millionrounds.com/company/kestra-medical-technologies-inc)** US **$138M** With 3 others - **Dec** **[FoRx Therapeutics](https://millionrounds.com/company/forx-therapeutics)** Series A · CH **$50M** With 1 other - **Dec** **[Protego Biopharma](https://millionrounds.com/company/protego-biopharma)** Series B · US · Firms' own news pages **$130M** With 9 others - **Sept** **[NRG Therapeutics](https://millionrounds.com/company/nrg-therapeutics)** Series B · GB · Firms' own news pages **$68M** With 6 others - **Jul** **[ARTBIO](https://millionrounds.com/company/artbio)** Series B · US **$132M** With 1 other - **Jun** **[Trevi Therapeutics](https://millionrounds.com/company/trevi-therapeutics)** US **$115M** With 3 others - **May** **[Ousia Pharma](https://millionrounds.com/company/ousia-pharma)** Venture · DK **Undisclosed** With 1 other - **May** **[Senti Biosciences](https://millionrounds.com/company/senti-biosciences)** Grant · US **$1.0M** With 4 others - **May** **[Antares Therapeutics](https://millionrounds.com/company/antares-therapeutics)** Series A · US **$177M** With 2 others - **Apr** **[Hydrocision](https://millionrounds.com/company/hydrocision)** Venture · US **$2.5M** Sole investor - **Mar** **[Nuvation Bio](https://millionrounds.com/company/nuvation-bio)** Debt · US **$150M** With 3 others - **Mar** **[Callio Therapeutics](https://millionrounds.com/company/callio-therapeutics)** Series A · US **$187M** With 3 others - **Jan** **[Windward Bio](https://millionrounds.com/company/windward-bio)** Series A · CH **$200M** With 4 others - **Jan** **[Alleviant Medical](https://millionrounds.com/company/alleviant-medical)** Venture · US · Vensana Capital **$90M** With 2 others - **2024** 9 rounds - **Nov** **[Beta Bionics](https://millionrounds.com/company/beta-bionics)** Series E · US **$60M** With 4 others - **Nov** **[Replimune Group](https://millionrounds.com/company/replimune-group)** US **$140M** With 5 others - **Aug** **[XII Medical](https://millionrounds.com/company/xii-medical)** Series B · US **$45M** With 1 other - **Jul** **[Scorpion Therapeutics](https://millionrounds.com/company/scorpion-therapeutics)** Series C · US **$150M** With 4 others - **Jul** **[Vanqua Bio](https://millionrounds.com/company/vanqua-bio)** Venture · US **$45M** With 3 others - **Jul** **[CatalYm](https://millionrounds.com/company/catalym)** Series D · DE **$150M** With 3 others - **Jun** **[Marea Therapeutics](https://millionrounds.com/company/marea-therapeutics)** Series B · US **$190M** With 3 others - **May** **[Bbot](https://millionrounds.com/company/bbot)** Venture · US **$200M** With 4 others - **Apr** **[Endeavor BioMedicines](https://millionrounds.com/company/endeavor-biomedicines)** Series C · US **$133M** With 2 others - **2023** 8 rounds - **Nov** **[Alpine Immune Sciences](https://millionrounds.com/company/alpine-immune-sciences)** US **$150M** With 4 others - **Nov** **[Eyebiotech](https://millionrounds.com/company/eyebiotech)** Series A · US **$65M** With 4 others - **Jul** **[Gossamer Bio](https://millionrounds.com/company/gossamer-bio)** US **$212M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **9 named** AR **Alexandra Rankel Pearsall** Chief Financial Officer i Form ADV AP **Anne-Mari Paster** Director i Filing they signed CP **Claudio Pier Antonio Nessi** Manager & Member i Form ADV FL **Francesco Luigi Draetta** Manager & Member i Form ADV KB **Kevin Brennan** A Director of the general partner of the General Partner i Filing they signed ME **Mark Emerson Russell** Chief Compliance Officer i Form ADV O(**Otello (nmn) Stampacchia** A Director of the general partner of the General Partner i Filing they signed RL **Richard Lim** Director i Filing they signed SA **Sharon Alvarez** A Director of the general partner of the General Partner i Filing they signed We also hold **16** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$1.7B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Omega Fund Management, LLC - **SEC number:** CRD 157753 Funds on its Form ADV **8** private funds, **$694M** in gross assets · filed Mar 2024 - Omega Fund VII, L.P. *Private equity* 87 investors $324M - Omega Fund VI, L.P. *Private equity* 45 investors $268M - Omega Fund V, L.P. *Private equity* 34 investors $68M - Omega Fund IV, L.P. *Private equity* 37 investors $29M - NET Assets of Omega Fund III, L.P. *Private equity* 15 investors $3.1M - Omega Fund II, L.P. *Private equity* 6 investors $1.7M - Life Sciences Holdings SPV I Fund, L.P. *Private equity* 1 investor $190K - Omega Fund VIII, L.P. *Private equity* 42 investors - ## What they claim to have backed From their own portfolio page (on their website) **0** of 4 we have independently watched raise Omega Fund V S3 Show + Tell Sscfundservices Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **1 in all** **[Santaris Pharma](https://millionrounds.com/company/santaris-pharma)** Bought by Roche **$450M** Aug 2014 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$580M** raised in Apr 2025 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Buyout Growth Pre-seed Median round joined **$88M** the round, not its cheque Alone, median **$2.6M** Led 8 of 104 rounds **8%** - **Sole investor:** 5 rounds - **Last cheque:** Sept 2026 - **Exits:** 1 from the portfolio Rounds by stage said on their site - Series A said *25* - Series B said *25* - Series C *14* - Venture *13* - Series D *3* - Buyout said *-* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Atlas Venture](https://millionrounds.com/fund/atlas-venture) 10 - [Perceptive Advisors](https://millionrounds.com/fund/perceptive-advisors) 10 - [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) 9 - [OrbiMed](https://millionrounds.com/fund/orbimed) 9 - [Polaris Partners](https://millionrounds.com/fund/polaris-partners) 8 - [Wellington Management](https://millionrounds.com/fund/wellington-management) 8 **Pitching Omega Funds?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Omega Funds. A count of rooms they were both in, not a relationship either has claimed. [**Atlas Venture** VC firm **10** rounds together](https://millionrounds.com/fund/atlas-venture)[**Perceptive Advisors** Asset manager **10** rounds together](https://millionrounds.com/fund/perceptive-advisors)[**Cormorant Asset Management** Private equity **9** rounds together](https://millionrounds.com/fund/cormorant-asset-management)[**OrbiMed** Private equity **9** rounds together](https://millionrounds.com/fund/orbimed)[**Polaris Partners** VC firm **8** rounds together](https://millionrounds.com/fund/polaris-partners)[**Wellington Management** VC firm **8** rounds together](https://millionrounds.com/fund/wellington-management)[**EcoR1 Capital** Private equity **7** rounds together](https://millionrounds.com/fund/ecor1-capital)[**Forbion Capital Partners** Private equity **7** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**ARCH Venture Partners** VC firm **6** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Fidelity** VC firm **6** rounds together](https://millionrounds.com/fund/fidelity)[**Google Ventures** Corporate VC **6** rounds together](https://millionrounds.com/fund/gv)[**Redmile Group** VC firm **6** rounds together](https://millionrounds.com/fund/redmile-group) ## Recently backed The latest companies Omega Funds put money into. [**Anaconda Biomed** $56M · Sept 2026](https://millionrounds.com/company/anaconda-biomed)[**Beta Bionics** $173M · Sept 2026](https://millionrounds.com/company/beta-bionics)[**Editas Medicine** $125M · May 2026](https://millionrounds.com/company/editas-medicine)[**Sana Biotechnology** $69M · May 2026](https://millionrounds.com/company/sana-biotechnology)[**Trevi Therapeutics** $173M · Apr 2026](https://millionrounds.com/company/trevi-therapeutics)[**Alveus Therapeutics Inc.** $197M · Feb 2026](https://millionrounds.com/company/alveus-therapeutics-inc) ## Mentioned on podcasts Episodes that name Omega Funds in their description, not their title. - [The Biotech Startups Podcast](https://millionrounds.com/podcasts/biotech-startups) 2 Jun 2025 · 37 min 🧬 Biotech Investing Unlocked: Mindset Shift, Risk, and Founder-First Lessons | Johnny Hu (Part 3/4) With [Johnny Hu](https://millionrounds.com/person/johnny-hu) Mentions [Menlo Ventures](https://millionrounds.com/fund/menlo-ventures)[Omega Funds](https://millionrounds.com/fund/omega-funds) Apple PodcastsShow page ## Quick answers about Omega Funds ### What does Omega Funds invest in? Omega Funds invests most often at Series A and Series B (63% of the rounds on record), in sectors such as Oncology, Immunology and Rare_diseases. ### How active is Omega Funds? 104 investments on record, 17 of them in the last 12 months, and it led 8. The most recent was in Sept 2026. ### What has Omega Funds invested in recently? Its most recent investments on record: Anaconda Biomed (Series C, Sept 2026), Beta Bionics (Undisclosed round, Sept 2026) and Vaderis Therapeutics (Series B, Aug 2026). ### How big are Omega Funds's cheques? The median round it joins is $88M. ### Does Omega Funds lead rounds? Sometimes: it led 8 of its 104 investments on record (8%). ### Where does Omega Funds invest? Most of the companies it backs are in the United States (83%) and Switzerland (8%). ### Is Omega Funds investing now? Yes: it is actively investing, with 17 investments in the last 12 months. ### Who does Omega Funds invest alongside? Most often Atlas Venture (10 rounds together), Perceptive Advisors (10 rounds together) and Cormorant Asset Management (9 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=omega-funds) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=omega-funds)